NPPB and type 2 diabetes mellitus: The limited focus on HF outcomes in most studies, while mechanistically appropriate given the biology of NT-proBNP, provides incomplete evidence regarding its utility for predicting atherothrombotic events, which represent a major component of cardiovascular risk in T2DM.